GlassScriptPhysician profile
Amy Iris Sullivan
NPI 1194463398
$3,152.90
in general payments reported to CMS, 2019-2025
12 companies · $755 in 2025
The $755 reported for 2025 was more than what 75% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $125 · 2023: $857 · 2024: $1,416 · 2025: $755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,028.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,027.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $736.84 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $600.60 | 2023-2025 | Spravato, Invega Sustenna |
| Neurocrine Biosciences, INC. | $419.11 | 2022-2025 | Ingrezza |
| Alkermes, INC. | $263.01 | 2023-2025 | Lybalvi, Aristada, Vivitrol |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $262.01 | 2023-2024 | Caplyta |
| Supernus Pharmaceuticals, INC. | $253.31 | 2023-2025 | Qelbree, Qelbree |
| Otsuka America Pharmaceutical, INC. | $161.20 | 2023-2024 | Rexulti, Nuedexta |
| Lundbeck LLC | $148.01 | 2023-2025 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $125.42 | 2023-2025 | Trintellix |
| Teva Pharmaceuticals USA, INC. | $95.65 | 2023-2025 | Austedo Xr, Uzedy, Austedo Xr |
| Corium, LLC | $71.62 | 2023-2024 | Azstarys |
| Janssen Biotech, INC. | $16.12 | 2024 | Spravato |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.